The latest NHS news, headlines and analysis from The NE Times.
The second wave of NHS dentistry reforms in England introduces new complex care pathways for patients with serious decay and gum disease, alongside changes to denture payments, as ministers try to improve access to NHS care.
Donna Ockenden's review into maternity care at Nottingham University Hospitals, billed as the largest of its kind in NHS history, is expected to detail deaths, stillbirths and serious injuries spanning 2012 to 2025.
Nottinghamshire Police have arrested two men on suspicion of misconduct in a public office over mortuary practices at Nottingham University Hospitals, a separate inquiry that has compounded scrutiny of the trust.
From 23 June, family doctors in England will be able to prescribe the weight-loss injection tirzepatide to prioritised patients, with eligibility widening and every patient required to take part in wrap-around lifestyle support.
A four-day walkout planned for the heatwave-hit week of 15 June was called off so that resident doctors in England could vote on a government offer worth an average 6.6 per cent and 4,500 new training places, with the ballot closing on 26 June.
The UK Health Security Agency has warned of health risks across London, the South East and parts of eastern and central England as temperatures climb, with older and unwell people most at risk.
A cross-party debate on the £12.8bn compensation scheme will press ministers to speed up payments to the victims of one of the NHS's worst disasters.
A national catch-up campaign running from June targets young children who have missed measles vaccinations, as a new combined MMRV jab protecting against chickenpox is introduced into the routine schedule.
Planned strikes by resident doctors in England have been suspended after a last-minute government offer including an average 6.6% pay rise and thousands of new training places, which will now go to a membership referendum.
The Health and Social Care Secretary has set out plans to accelerate the digitisation of the NHS, telling the ConfedExpo conference that the service cannot manage its way out of pressure but must reform through technology.
A walkout that threatened to coincide with a heatwave and the World Cup was suspended hours before it began, after the BMA and government struck a revised pay and jobs offer now heading to a members' vote.
MPs want ministers to walk away from a £330m contract over the firm's 'values'. The instinct is understandable, but ditching a working system on principle alone would be a serious mistake unless we are honest about what replaces it.
From 23 June, more people in England will qualify for tirzepatide on the NHS as the BMI threshold for primary-care prescribing drops, in the next phase of a carefully managed rollout.
The latest figures show the elective waiting list in England standing at more than 7.2 million cases, with progress on bringing it down described as sluggish and key cancer and emergency targets still being missed.
Members of the British Medical Association are set to walk out from 15 to 19 June after talks over pay restoration failed to produce an improved offer.
The chancellor unveiled her first multi-year settlement, boosting health, defence and nuclear power, but warned that some departments would lose out.
Hospitals in England managed nearly 2.46 million A&E attendances in May, the highest for any month on record, as a heatwave drove a surge in demand and June set a fresh record for the month.
GPs in England will be able to prescribe the weight-loss drug Mounjaro to a wider group of patients from late June, as the NHS lowers the BMI threshold for the next phase of its rollout.
The Chancellor set departmental budgets for the rest of the decade, prioritising health and security while conceding that some areas would feel the squeeze.
NHS England has announced that eligible men with early prostate cancer will be offered SABR, a targeted treatment that cuts the number of sessions from at least 20 to five.
Thousands of men with localised prostate cancer will be offered SABR, a high-precision radiotherapy that can be delivered in five sessions instead of 20 or more, after a £70 million investment in new machines across England.
Around 400 women a year with platinum-resistant ovarian cancer will be offered Elahere, a targeted therapy shown to extend survival compared with standard chemotherapy.
Up to 400 women a year with hard-to-treat ovarian cancer will be offered mirvetuximab soravtansine, a targeted therapy shown to extend survival, after NICE recommended it for use on the NHS in England.
A major international trial led by UK researchers found that a 50-gene tumour test can safely identify many women who gain no benefit from chemotherapy, with near-identical survival five years on.